Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2012, Article ID 139365, 13 pages
http://dx.doi.org/10.1155/2012/139365
Review Article

Autoantibodies and Resident Renal Cells in the Pathogenesis of Lupus Nephritis: Getting to Know the Unknown

Department of Medicine, Queen Mary Hospital, University of Hong Kong, Pokfulam, Hong Kong

Received 20 February 2012; Accepted 26 March 2012

Academic Editor: Chaim Putterman

Copyright © 2012 Susan Yung and Tak Mao Chan. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. S. Cameron, “Lupus nephritis,” Journal of the American Society of Nephrology, vol. 10, no. 2, pp. 413–424, 1999. View at Google Scholar · View at Scopus
  2. B. H. Hahn, “Antibodies to DNA,” The New England Journal of Medicine, vol. 338, no. 19, pp. 1359–1368, 1998. View at Publisher · View at Google Scholar · View at Scopus
  3. F. M. Ebling and B. H. Hahn, “Pathogenic subsets of antibodies to DNA,” International reviews of immunology, vol. 5, no. 1, pp. 79–95, 1989. View at Google Scholar · View at Scopus
  4. T. M. Chan, J. K. H. Leung, S. K. N. Ho, and S. Yung, “Mesangial cell-binding anti-DNA antibodies in patients with systemic lupus erythematosus,” Journal of the American Society of Nephrology, vol. 13, no. 5, pp. 1219–1229, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Yung, R. C. W. Tsang, Y. Sun, J. K. H. Leung, and T. M. Chan, “Effect of human anti-DNA antibodies on proximal renal tubular epithelial cell cytokine expression: implications on tubulointerstitial inflammation in lupus nephritis,” Journal of the American Society of Nephrology, vol. 16, no. 11, pp. 3281–3294, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. D. M. D'Andrea, B. Coupaye-Gerard, T. R. Kleyman, M. H. Foster, and M. P. Madaio, “Lupus autoantibodies interact directly with distinct glomerular and vascular cell surface antigens,” Kidney International, vol. 49, no. 5, pp. 1214–1221, 1996. View at Google Scholar · View at Scopus
  7. E. J. Lewis and M. M. Schwartz, “Pathology of lupus nephritis,” Lupus, vol. 14, no. 1, pp. 31–38, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. M. H. Foster, B. Cizman, and M. P. Madaio, “Nephritogenic autoantibodies in systemic lupus erythematosus: immunochemical properties, mechanisms of immune deposition, and genetic origins,” Laboratory Investigation, vol. 69, no. 5, pp. 494–507, 1993. View at Google Scholar · View at Scopus
  9. O. P. Rekvig, M. Kalaaji, and H. Nossent, “Anti-DNA antibody subpopulations and lupus nephritis,” Autoimmunity Reviews, vol. 3, no. 2, pp. 1–6, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. G. S. Hill, M. Delahousse, D. Nochy, C. Mandet, and J. Bariéty, “Proteinuria and tubulointerstitial lesions in lupus nephritis,” Kidney International, vol. 60, no. 5, pp. 1893–1903, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. P. I. Sidiropoulos, H. D. Kritikos, and D. T. Boumpas, “Lupus nephritis flares,” Lupus, vol. 14, no. 1, pp. 49–52, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. B. P. Tsao, K. Ohnishi, H. Cheroutre et al., “Failed self-tolerance and autoimmunity in IgG anti-DNA transgenic mice,” The Journal of Immunology, vol. 149, no. 1, pp. 350–358, 1992. View at Google Scholar · View at Scopus
  13. D. V. Vlahakos, M. H. Foster, S. Adams et al., “Anti-DNA antibodies form immune deposits at distinct glomerular and vascular sites,” Kidney International, vol. 41, no. 6, pp. 1690–1700, 1992. View at Google Scholar · View at Scopus
  14. J. B. Winfield, I. Faiferman, and D. Koffler, “Avidity of anti-DNA antibodies in serum and IgG glomerular eluates from patients with systemic lupus erythematosus. Association of high avidity antinative DNA antibody with glomerulonephritis,” The Journal of Clinical Investigation, vol. 59, no. 1, pp. 90–96, 1977. View at Google Scholar
  15. F. Ebling and B. H. Hahn, “Restricted subpopulations of DNA antibodies in kidneys of mice with systemic lupus. Comparison of antibodies in serum and renal eluates,” Arthritis and Rheumatism, vol. 23, no. 4, pp. 392–403, 1980. View at Google Scholar · View at Scopus
  16. B. Deocharan, X. Qing, J. Lichauco, and C. Putterman, “α-actinin is a cross-reactive renal target for pathogenic anti-DNA aptibodies,” The Journal of Immunology, vol. 168, no. 6, pp. 3072–3078, 2002. View at Google Scholar · View at Scopus
  17. G. Mostoslavsky, R. Fischel, N. Yachimovich et al., “Lupus anti-DNA autoantibodies cross-react with a glomerular structural protein: a case for tissue injury by molecular mimicry,” European Journal of Immunology, vol. 31, no. 4, pp. 1221–1227, 2001. View at Google Scholar
  18. S. Yung, K. F. Cheung, Q. Zhang, and T. M. Chan, “Anti-dsDNA antibodies bind to mesangial annexin II in lupus nephritis,” Journal of the American Society of Nephrology, vol. 21, no. 11, pp. 1912–1927, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. K. A. Bernstein, R. D. Valerio, and J. B. Lefkowith, “Glomerular binding activity in MRL lpr serum consists of antibodies that bind to a DNA/histone/type IV collagen complex,” The Journal of Immunology, vol. 154, no. 5, pp. 2424–2433, 1995. View at Google Scholar · View at Scopus
  20. R. P. Singh, R. T. Waldron, and B. H. Hahn, “Genes, tolerance and systemic autoimmunity,” Autoimmunity Reviews. In press.
  21. Z. Liu and A. Davidson, “BAFF and selection of autoreactive B cells,” Trends in Immunology, vol. 32, no. 8, pp. 388–394, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. V. R. Kelley, “Leukocyte-renal epithelial cell interactions regulate lupus nephritis,” Seminars in Nephrology, vol. 27, no. 1, pp. 59–68, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. E. M. Tan, P. H. Schur, R. I. Carr, and H. G. Kunkel, “Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus,” The Journal of Clinical Investigation, vol. 45, no. 11, pp. 1732–1740, 1966. View at Google Scholar · View at Scopus
  24. E. J. ter Borg, G. Horst, E. J. Hummel, P. C. Limburg, and C. G. M. Kallenberg, “Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study,” Arthritis and Rheumatism, vol. 33, no. 5, pp. 634–643, 1990. View at Publisher · View at Google Scholar · View at Scopus
  25. E. J. ter Borg, G. Horst, E. Hummel, P. C. Limburg, and C. G. M. Kallenberg, “Rises in anti-double stranded DNA antibody levels prior to exacerbations of systemic lupus erythematosus are not merely due to polyclonal B cell activation,” Clinical Immunology and Immunopathology, vol. 59, no. 1, pp. 117–128, 1991. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Kalaaji, E. Mortensen, L. Jørgensen, R. Olsen, and O. P. Rekvig, “Nephritogenic lupus antibodies recognize glomerular basement membrane-associated chromatin fragments released from apoptotic intraglomerular cells,” The American Journal of Pathology, vol. 168, no. 6, pp. 1779–1792, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. D. A. Isenberg, J. J. Manson, M. R. Ehrenstein, and A. Rahman, “Fifty years of anti-ds DNA antibodies: are we approaching journey's end?” Rheumatology, vol. 46, no. 7, pp. 1052–1056, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Yung and T. M. Chan, “Anti-DNA antibodies in the pathogenesis of lupus nephritis—The emerging mechanisms,” Autoimmunity Reviews, vol. 7, no. 4, pp. 317–321, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Rahman and D. A. Isenberg, “Systemic lupus erythematosus,” The New England Journal of Medicine, vol. 358, no. 9, pp. 929–939, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Mannik, C. E. Merrill, L. D. Stamps, and M. H. Wener, “Multiple autoantibodies form the glomerular immune deposits in patients with systemic lupus erythematosus,” The Journal of Rheumatology, vol. 30, no. 7, pp. 1495–1504, 2003. View at Google Scholar · View at Scopus
  31. C. Grootscholten, J. W. C. Dieker, F. D. McGrath et al., “A prospective study of anti-chromatin and anti-C1q autoantibodies in patients with proliferative lupus nephritis treated with cyclophosphamide pulses or azathioprine/methylprednisolone,” Annals of the Rheumatic Diseases, vol. 66, no. 5, pp. 693–696, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. C. Bigler, M. Lopez-Trascasa, E. Potlukova et al., “Antinucleosome antibodies as a marker of active proliferative lupus nephritis,” American Journal of Kidney Diseases, vol. 51, no. 4, pp. 624–629, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. S. M. Korbet, M. M. Schwartz, J. Evans, and E. J. Lewis, “Severe lupus nephritis: racial differences in presentation and outcome,” Journal of the American Society of Nephrology, vol. 18, no. 1, pp. 244–254, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. C. G. Moura, I. Lima, L. Barbosa et al., “Anti-C1q antibodies: association with nephritis and disease activity in systemic lupus erythematosus,” Journal of Clinical Laboratory Analysis, vol. 23, no. 1, pp. 19–23, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Trendelenburg, M. Lopez-Trascasa, E. Potlukova et al., “High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis,” Nephrology Dialysis Transplantation, vol. 21, no. 11, pp. 3115–3121, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. J. J. Manson, A. Ma, P. Rogers et al., “Relationship between anti-dsDNA, anti-nucleosome and anti-alpha-actinin antibodies and markers of renal disease in patients with lupus nephritis: a prospective longitudinal study,” Arthritis Research and Therapy, vol. 11, no. 5, article no. R154, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. V. Chindalore, B. Neas, and M. Reichlin, “The association between anti-ribosomal P antibodies and active nephritis in systemic lupus erythematosus,” Clinical Immunology and Immunopathology, vol. 87, no. 3, pp. 292–296, 1998. View at Publisher · View at Google Scholar · View at Scopus
  38. K. H. Sun, W. T. Liu, C. Y. Tsai, S. J. Tang, S. H. Han, and C. L. Yu, “Anti-dsDNA antibodies cross-react with ribosomal P proteins expressed on the surface of glomerular mesangial cells to exert a cytostatic effect,” Immunology, vol. 85, no. 2, pp. 262–269, 1995. View at Google Scholar
  39. T. Dorner, C. Heimbacher, N. L. Farner, and P. E. Lipsky, “Enhanced mutational activity of Vkappa gene rearrangements in systemic lupus erythematosus,” Clinical Immunology, vol. 92, no. 2, pp. 188–196, 1999. View at Google Scholar
  40. N. F. Rothfield and B. D. Stollar, “The relation of immunoglobulin class, pattern of anti-nuclear antibody, and complement-fixing antibodies to DNA in sera from patients with systemic lupus erythematosus,” The Journal of Clinical Investigation, vol. 46, no. 11, pp. 1785–1794, 1967. View at Google Scholar · View at Scopus
  41. T. Tojo and G. J. Friou, “Lupus nephritis: varying complement-fixing properties of immunoglobulin G antibodies to antigens of cell nuclei,” Science, vol. 161, no. 3844, pp. 904–906, 1968. View at Google Scholar · View at Scopus
  42. M. R. Arbuckle, M. T. McClain, M. V. Rubertone et al., “Development of autoantibodies before the clinical onset of systemic lupus erythematosus,” The New England Journal of Medicine, vol. 349, no. 16, pp. 1526–1533, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. T. Pincus, P. H. Schur, J. A. Rose, J. L. Decker, and N. Talal, “Measurement of serum DNA-binding activity in systemic lupus erythematosus,” The New England Journal of Medicine, vol. 281, no. 13, pp. 701–705, 1969. View at Google Scholar · View at Scopus
  44. P. H. Schur and J. Sandson, “Immunologic factors and clinical activity in systemic lupus erythematosus,” The New England Journal of Medicine, vol. 278, no. 10, pp. 533–538, 1968. View at Google Scholar · View at Scopus
  45. S. Izui, P. H. Lambert, and P. A. Miescher, “Failure to detect circulating DNA-anti-DNA complexes by four radioimmunological methods in patients with systemic lupus erythematosus,” Clinical and Experimental Immunology, vol. 30, no. 3, pp. 384–392, 1977. View at Google Scholar · View at Scopus
  46. W. Emlen and M. Mannik, “Clearance of circulating DNA-anti-DNA immune complexes in mice,” Journal of Experimental Medicine, vol. 155, no. 4, pp. 1210–1215, 1982. View at Google Scholar · View at Scopus
  47. W. Burny, P. Lebrun, J. P. Cosyns, and J. M. R. Saint-Remy, “Treatment with dsDNA-anti-dsDNA antibody complexes extends survival, decreases anti-dsDNA antibody production and reduces severity of nephritis in MRL1pr mice,” Lupus, vol. 6, no. 1, pp. 4–17, 1997. View at Google Scholar · View at Scopus
  48. J. H. M. Berden, R. Licht, M. C. J. van Bruggen, and W. J. M. Tax, “Role of nucleosomes for induction and glomerular binding of autoantibodies in lupus nephritis,” Current Opinion in Nephrology and Hypertension, vol. 8, no. 3, pp. 299–306, 1999. View at Publisher · View at Google Scholar · View at Scopus
  49. O. P. Rekvig and J. C. Nossent, “Anti-double-stranded DNA antibodies, nucleosomes, and systemic lupus erythematosus: a time for new paradigms?” Arthritis and Rheumatism, vol. 48, no. 2, pp. 300–312, 2003. View at Publisher · View at Google Scholar · View at Scopus
  50. M. Kalaaji, K. A. Fenton, E. S. Mortensen et al., “Glomerular apoptotic nucleosomes are central target structures for nephritogenic antibodies in human SLE nephritis,” Kidney International, vol. 71, no. 7, pp. 664–672, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. C. Kramers, M. N. Hylkema, M. C. J. van Bruggen et al., “Anti-nucleosome antibodies complexed to nucleosomal antigens show anti-DNA reactivity and bind to rat glomerular basement membrane in vivo,” The Journal of Clinical Investigation, vol. 94, no. 2, pp. 568–577, 1994. View at Google Scholar · View at Scopus
  52. A. Hedberg, S. Fismen, K. A. Fenton et al., “Heparin exerts a dual effect on murine lupus nephritis by enhancing enzymatic chromatin degradation and preventing chromatin binding in glomerular membranes,” Arthritis and Rheumatism, vol. 63, no. 4, pp. 1065–1075, 2011. View at Publisher · View at Google Scholar · View at Scopus
  53. E. S. Mortensen and O. P. Rekvig, “Nephritogenic potential of anti-DNA antibodies against necrotic nucleosomes,” Journal of the American Society of Nephrology, vol. 20, no. 4, pp. 696–704, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. J. A. Simón, J. Cabiedes, E. Ortiz, J. Alcocer-Varela, and J. Sánchez-Guerrero, “Anti-nucleosome antibodies in patients with systemic lupus erythematosus of recent onset. Potential utility as diagnostic tool and disease activity marker,” Rheumatology, vol. 43, no. 2, pp. 220–224, 2004. View at Publisher · View at Google Scholar · View at Scopus
  55. K. P. Ng, J. J. Manson, A. Rahman, and D. A. Isenberg, “Association of antinucleosome antibodies with disease flare in serologically active clinically quiescent patients with systemic lupus erythematosus,” Arthritis Care and Research, vol. 55, no. 6, pp. 900–904, 2006. View at Publisher · View at Google Scholar · View at Scopus
  56. M. Waldman and M. P. Madaio, “Pathogenic autoantibodies in lupus nephritis,” Lupus, vol. 14, no. 1, pp. 19–24, 2005. View at Publisher · View at Google Scholar · View at Scopus
  57. E. Raz, M. Brezis, E. Rosenmann, and D. Eilat, “Anti-DNA antibodies bind directly to renal antigens and induce kidney dysfunction in the isolated perfused rat kidney,” The Journal of Immunology, vol. 142, no. 9, pp. 3076–3082, 1989. View at Google Scholar · View at Scopus
  58. M. R. Krishnan, C. Wang, and T. N. Marion, “Anti-DNA autoantibodies initiate experimental lupus nephritis by binding directly to the glomerular basement membrane in mice,” Kidney International. In press.
  59. S. T. Waters, M. McDuffie, H. Bagavant et al., “Breaking tolerance to double stranded DNA, nucleosome, and other nuclear antigens is not required for the pathogenesis of lupus glomerulonephritis,” Journal of Experimental Medicine, vol. 199, no. 2, pp. 255–264, 2004. View at Publisher · View at Google Scholar · View at Scopus
  60. S. R. Christensen, M. Kashgarian, L. Alexopoulou, R. A. Flavell, S. Akira, and M. J. Shlomchik, “Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus,” Journal of Experimental Medicine, vol. 202, no. 2, pp. 321–331, 2005. View at Publisher · View at Google Scholar · View at Scopus
  61. R. M. Termaat, K. J. M. Assmann, J. P. H. F. van Son, H. B. P. M. Dijkman, R. A. P. Koene, and J. H. M. Berden, “Antigen-specificity of antibodies bound to glomeruli of mice with systemic lupus erythematosus-like syndromes,” Laboratory Investigation, vol. 68, no. 2, pp. 164–173, 1993. View at Google Scholar · View at Scopus
  62. T. Haramoto, H. Makino, S. Ikeda, J. Wieslader, and Z. Ota, “Ultrastructural localization of the three major basement membrane components—Type IV collagen, heparan sulfate proteoglycan and laminin—in human membranous glomerulonephritis,” American Journal of Nephrology, vol. 14, no. 1, pp. 30–36, 1994. View at Google Scholar · View at Scopus
  63. P. Faaber, T. P. M. Rijke, L. B. A. van de Putte, P. J. Capel, and J. H. Berden, “Cross-reactivity of human and murine anti-DNA antibodies with heparan sulfate. The major glycosaminoglycan in glomerular basement membranes,” The Journal of Clinical Investigation, vol. 77, no. 6, pp. 1824–1830, 1986. View at Google Scholar · View at Scopus
  64. N. B. Blatt and G. D. Glick, “Anti-DNA autoantibodies and systemic lupus erythematosus,” Pharmacology and Therapeutics, vol. 83, no. 2, pp. 125–139, 1999. View at Publisher · View at Google Scholar · View at Scopus
  65. D. M. Klinman, R. A. Eisenberg, and A. D. Steinberg, “Development of the autoimmune B cell repertoire in MRL-lpr/lpr mice,” The Journal of Immunology, vol. 144, no. 2, pp. 506–511, 1990. View at Google Scholar · View at Scopus
  66. J. P. Grande, “Experimental models of lupus nephritis,” Contributions to Nephrology, vol. 169, pp. 183–197, 2011. View at Publisher · View at Google Scholar · View at Scopus
  67. J. J. Weening, V. D. D'Agati, M. M. Schwartz et al., “The classification of glomerulonephritis in systemic lupus erythematosus revisited,” Journal of the American Society of Nephrology, vol. 15, no. 2, pp. 241–250, 2004. View at Publisher · View at Google Scholar · View at Scopus
  68. K. S. Peterson, J. F. Huang, J. Zhu et al., “Characterization of heterogeneity in the molecular pathogenesis of lupus nephritis from transcriptional profiles of laser-captured glomeruli,” The Journal of Clinical Investigation, vol. 113, no. 12, pp. 1722–1733, 2004. View at Publisher · View at Google Scholar · View at Scopus
  69. T. M. Chan, G. Frampton, N. A. Staines, P. Hobby, G. J. Perry, and J. S. Cameron, “Different mechanisms by which anti-DNA MoAbs bind to human endothelial cells and glomerular mesangial cells,” Clinical and Experimental Immunology, vol. 88, no. 1, pp. 68–74, 1992. View at Google Scholar · View at Scopus
  70. T. M. Chan, G. Frampton, and J. S. Cameron, “Identification of DNA-binding proteins on human umbilical vein endothelial cell plasma membrane,” Clinical and Experimental Immunology, vol. 91, no. 1, pp. 110–114, 1993. View at Google Scholar · View at Scopus
  71. D. J. Zack, M. Stempniak, A. L. Wong, C. Taylor, and R. H. Weisbart, “Mechanisms of cellular penetration and nuclear localization of an anti-double strand DNA autoantibody,” The Journal of Immunology, vol. 157, no. 5, pp. 2082–2088, 1996. View at Google Scholar · View at Scopus
  72. C. L. Yu, K. H. Sun, C. Y. Tsai, S. C. Hsieh, and H. S. Yu, “Anti-dsDNA antibody up-regulates interleukin 6, but not cyclo-oxygenase, gene expression in glomerular mesangial cells: a marker of immune-mediated renal damage?” Inflammation Research, vol. 50, no. 1, pp. 12–18, 2001. View at Publisher · View at Google Scholar · View at Scopus
  73. K. N. Lai, J. C. Leung, K. Bik Lai, P. K. Li, and C. K. Lai, “Anti-DNA autoantibodies stimulate the release of interleukin-1 and interleukin-6 from endothelial cells,” The Journal of Pathology, vol. 178, no. 4, pp. 451–457, 1996. View at Google Scholar
  74. K. N. Lai, J. C. K. Leung, K. B. Lai, and C. K. W. Lai, “Effect of anti-DNA autoantibodies on the gene expression of interleukin 8, transforming growth factor-β, and nitric oxide synthase in cultured endothelial cells,” Scandinavian Journal of Rheumatology, vol. 26, no. 6, pp. 461–467, 1997. View at Google Scholar · View at Scopus
  75. S. Yung, R. C. W. Tsang, J. K. H. Leung, and T. M. Chan, “Increased mesangial cell hyaluronan expression in lupus nephritis is mediated by anti-DNA antibody-induced IL-1β,” Kidney International, vol. 69, no. 2, pp. 272–280, 2006. View at Publisher · View at Google Scholar · View at Scopus
  76. S. Yung, Q. Zhang, C. Z. Zhang, K. W. Chan, S. L. Lui, and T. M. Chan, “Anti-DNA antibody induction of protein kinase C phosphorylation and fibronectin synthesis in human and murine lupus and the effect of mycophenolic acid,” Arthritis and Rheumatism, vol. 60, no. 7, pp. 2071–2082, 2009. View at Publisher · View at Google Scholar · View at Scopus
  77. S. Trivedi, M. Zeier, and J. Reiser, “Role of podocytes in lupus nephritis,” Nephrology Dialysis Transplantation, vol. 24, no. 12, pp. 3607–3612, 2009. View at Publisher · View at Google Scholar · View at Scopus
  78. D. Schlöndorff and B. Banas, “The mesangial cell revisited: no cell is an island,” Journal of the American Society of Nephrology, vol. 20, no. 6, pp. 1179–1187, 2009. View at Publisher · View at Google Scholar · View at Scopus
  79. H. E. Abboud, “Growth factors and the mesangium,” Journal of the American Society of Nephrology, vol. 2, no. 10, pp. S185–S189, 1992. View at Google Scholar · View at Scopus
  80. W. Zhou, J. E. Marsh, and S. H. Sacks, “Intrarenal synthesis of complement,” Kidney International, vol. 59, no. 4, pp. 1227–1235, 2001. View at Publisher · View at Google Scholar · View at Scopus
  81. K. Fenton, S. Fismen, A. Hedberg et al., “Anti-dsDNA antibodies promote initiation, and acquired loss of renal dnase1 promotes progression of lupus nephritis in autoimmune (NZB × NZW)F1 Mice,” Plos ONE, vol. 4, no. 12, Article ID e8474, 2009. View at Publisher · View at Google Scholar · View at Scopus
  82. J. J. Timmerman, D. J. Van Gijlswijk-Janssen, S. W. Van Der Kooij, L. A. Van Es, and M. R. Daha, “Antigen-antibody complexes enhance the production of complement component C3 by human mesangial cells,” Journal of the American Society of Nephrology, vol. 8, no. 8, pp. 1257–1265, 1997. View at Google Scholar · View at Scopus
  83. K. A. Fenton, B. Tømmers, T. N. Marion, and O. P. Rekvig, “Pure anti-dsDNA mAbs need chromatin structures to promote glomerular mesangial deposits in BALB/c mice,” Autoimmunity, vol. 43, no. 2, pp. 179–188, 2010. View at Publisher · View at Google Scholar · View at Scopus
  84. X. Qing, J. Zavadil, M. B. Crosby et al., “Nephritogenic anti-DNA antibodies regulate gene expression in MRL/lpr mouse glomerular mesangial cells,” Arthritis and Rheumatism, vol. 54, no. 7, pp. 2198–2210, 2006. View at Publisher · View at Google Scholar · View at Scopus
  85. C. L. Yu, M. H. Huang, C. Y. Tsai et al., “The effect of human polyclonal anti-dsDNA autoantibodies on apoptotic gene expression in cultured rat glomerular mesangial cells,” Scandinavian Journal of Rheumatology, vol. 27, no. 1, pp. 54–60, 1998. View at Publisher · View at Google Scholar · View at Scopus
  86. X. Qing, M. Pitashny, D. B. Thomas, F. J. Barrat, M. P. Hogarth, and C. Putterman, “Pathogenic anti-DNA antibodies modulate gene expression in mesangial cells: involvement of HMGB1 in anti-DNA antibody-induced renal injury,” Immunology Letters, vol. 121, no. 1, pp. 61–73, 2008. View at Publisher · View at Google Scholar · View at Scopus
  87. C. A. Otey and O. Carpen, “α-actinin revisited: a fresh look at an old player,” Cell Motility and the Cytoskeleton, vol. 58, no. 2, pp. 104–111, 2004. View at Publisher · View at Google Scholar · View at Scopus
  88. S. Yung, A. Woods, T. M. Chan, M. Davies, J. D. Williams, and J. R. Couchman, “Syndecan-4 up-regulation in proliferative renal disease is related to microfilament organization,” The FASEB journal, vol. 15, no. 9, pp. 1631–1633, 2001. View at Publisher · View at Google Scholar · View at Scopus
  89. Z. Zhao, B. Deocharan, P. E. Scherer, L. J. Ozelius, and C. Putterman, “Differential binding of cross-reactive anti-DNA antibodies to mesangial cells: the role of α-actinin,” The Journal of Immunology, vol. 176, no. 12, pp. 7704–7714, 2006. View at Google Scholar · View at Scopus
  90. J. E. Mjelle, O. P. Rekvig, J. Van Der Vlag, and K. A. Fenton, “Nephritogenic antibodies bind in glomeruli through interaction with exposed chromatin fragments and not with renal cross-reactive antigens,” Autoimmunity, vol. 44, no. 5, pp. 373–383, 2011. View at Publisher · View at Google Scholar · View at Scopus
  91. D. M. Waisman, “Annexin II tetramer: structure and function,” Molecular and Cellular Biochemistry, vol. 149-150, pp. 301–322, 1995. View at Publisher · View at Google Scholar · View at Scopus
  92. A. B. Deora, G. Kreitzer, A. T. Jacovina, and K. A. Hajjar, “An annexin 2 phosphorylation switch mediates p11-dependent translocation of annexin 2 to the cell surface,” The Journal of Biological Chemistry, vol. 279, no. 42, pp. 43411–43418, 2004. View at Publisher · View at Google Scholar · View at Scopus
  93. C. Bellagamba, I. Hubaishy, J. D. Bjorge, S. L. Fitzpatrick, D. J. Fujita, and D. M. Waisman, “Tyrosine phosphorylation of annexin II tetramer is stimulated by membrane binding,” The Journal of Biological Chemistry, vol. 272, no. 6, pp. 3195–3199, 1997. View at Publisher · View at Google Scholar · View at Scopus
  94. Q. Ling, A. T. Jacovina, A. Deora et al., “Annexin II regulates fibrin homeostasis and neoangiogenesis in vivo,” The Journal of Clinical Investigation, vol. 113, no. 1, pp. 38–48, 2004. View at Publisher · View at Google Scholar · View at Scopus
  95. J. Zhang and K. R. McCrae, “Annexin A2 mediates endothelial cell activation by antiphospholipid/anti-β2 glycoprotein I antibodies,” Blood, vol. 105, no. 5, pp. 1964–1969, 2005. View at Publisher · View at Google Scholar · View at Scopus
  96. D. Alarcon Segovia and L. Llorente, “Antibody penetration into living cells. IV. Different effects of anti-native DNA and anti-ribonucleoprotein IgG on the cell cycle of activated Tγ cells,” Clinical and Experimental Immunology, vol. 52, no. 2, pp. 365–371, 1983. View at Google Scholar · View at Scopus
  97. K. Yanase, R. M. Smith, B. Cizman et al., “A subgroup of murine monoclonal anti-deoxyribonucleic acid antibodies traverse the cytoplasm and enter the nucleus in a time-and temperature-dependent manner,” Laboratory Investigation, vol. 71, no. 1, pp. 52–60, 1994. View at Google Scholar · View at Scopus
  98. K. Yanase, R. M. Smith, A. Puccetti, L. Jarett, and M. P. Madaio, “Receptor-mediated cellular entry of nuclear localizing anti-DNA antibodies via myosin 1,” The Journal of Clinical Investigation, vol. 100, no. 1, pp. 25–31, 1997. View at Google Scholar · View at Scopus
  99. D. Alarcon-Segovia, A. Ruiz-Arguelles, and E. Fishbein, “Antibody to nuclear ribonucleoprotein penetrates live human mononuclear cells through Fc receptors,” Nature, vol. 271, no. 5640, pp. 67–69, 1978. View at Google Scholar · View at Scopus
  100. D. Alarcon-Segovia, A. Ruiz-Arguelles, and L. Llorente, “Antibody penetration into living cells. II. Anti-ribonucleoprotein IgG penetrates into Tγ lymphocytes causing their deletion and the abrogation of suppressor function,” The Journal of Immunology, vol. 122, no. 5, pp. 1855–1862, 1979. View at Google Scholar · View at Scopus
  101. M. Koscec, E. Koren, M. Wolfson-Reichlin et al., “Autoantibodies to ribosomal P proteins penetrate into live hepatocytes and cause cellular dysfunction in culture,” The Journal of Immunology, vol. 159, no. 4, pp. 2033–2041, 1997. View at Google Scholar · View at Scopus
  102. S. Lisi, M. Sisto, R. Soleti et al., “Fcγ receptors mediate internalization of anti-Ro and anti-La autoantibodies from Sjögren's syndrome and apoptosis in human salivary gland cell line A-253,” Journal of Oral Pathology and Medicine, vol. 36, no. 9, pp. 511–523, 2007. View at Publisher · View at Google Scholar · View at Scopus
  103. B. Ryffel, B. D. Car, H. Gunn, D. Roman, P. Hiestand, and M. J. Mihatsch, “Interleukin-6 exacerbates glomerulonephritis in (NZB × NZW)F1 mice,” The American Journal of Pathology, vol. 144, no. 5, pp. 927–937, 1994. View at Google Scholar · View at Scopus
  104. D. Alarcón-Segovia, “Antinuclear antibodies: to penetrate or not to penetrate, that was the question,” Lupus, vol. 10, no. 5, pp. 315–318, 2001. View at Publisher · View at Google Scholar · View at Scopus
  105. A. Ruiz-Argüelles, L. Rivadeneyra-Espinoza, and D. Alarcón-Segovia, “Antibody penetration into living cells: pathogenic, preventive and immuno-therapeutic implications,” Current Pharmaceutical Design, vol. 9, no. 23, pp. 1881–1887, 2003. View at Publisher · View at Google Scholar · View at Scopus
  106. K. Yanase and M. P. Madaio, “Nuclear localizing anti-DNA antibodies enter cells via caveoli and modulate expression of caveolin and p53,” Journal of Autoimmunity, vol. 24, no. 2, pp. 145–151, 2005. View at Publisher · View at Google Scholar · View at Scopus
  107. D. Vlahakos, M. H. Foster, A. A. Ucci, K. J. Barrett, S. K. Datta, and M. P. Madaio, “Murine monoclonal anti-DNA antibodies penetrate cells, bind to nuclei, and induce glomerular proliferation and proteinuria in vivo,” Journal of the American Society of Nephrology, vol. 2, no. 8, pp. 1345–1354, 1992. View at Google Scholar · View at Scopus
  108. C. Gomez-Guerrero, P. Hernandez-Vargas, O. Lopez-Franco, G. Ortiz-Munoz, and J. Egido, “Mesangial cells and glomerular inflammation: from the pathogenesis to novel therapeutic approaches,” Current Drug Targets Inflammation and Allergy, vol. 4, no. 3, pp. 341–351, 2005. View at Google Scholar
  109. B. J. Ballermann, “Contribution of the endothelium to the glomerular permselectivity barrier in health and disease,” Nephron. Physiology, vol. 106, no. 2, pp. 19–25, 2007. View at Publisher · View at Google Scholar · View at Scopus
  110. R. J. Quigg, “Complement and autoimmune glomerular diseases,” Current Directions in Autoimmunity, vol. 7, pp. 165–180, 2004. View at Google Scholar · View at Scopus
  111. T. Nagao, M. Matsumura, A. Mabuchi et al., “Up-regulation of adhesion molecule expression in glomerular endothelial cells by anti-myeloperoxidase antibody,” Nephrology Dialysis Transplantation, vol. 22, no. 1, pp. 77–87, 2007. View at Publisher · View at Google Scholar · View at Scopus
  112. M. F. Liu and H. Y. Lei, “Anti-endothelial cell antibodies in patients with systemic lupus erythematosus,” Journal of the Formosan Medical Association, vol. 90, no. 3, pp. 221–224, 1991. View at Google Scholar · View at Scopus
  113. M. X. Wang, R. G. Walker, and P. Kincaid-Smith, “Clinicopathologic associations of anti-endothelial cell antibodies in immunoglobulin A nephropathy and lupus nephritis,” American Journal of Kidney Diseases, vol. 22, no. 3, pp. 378–386, 1993. View at Google Scholar · View at Scopus
  114. T. M. Chan and I. K. P. Cheng, “A prospective study on anti-endothelial cell antibodies in patients with systemic lupus erythematosus,” Clinical Immunology and Immunopathology, vol. 78, no. 1, pp. 41–46, 1996. View at Publisher · View at Google Scholar · View at Scopus
  115. T. M. Chan, G. Frampton, D. R. W. Jayne, G. J. Perry, C. M. Lockwood, and J. S. Cameron, “Clinical significance of anti-endothelial cell antibodies in systemic vasculitis: a longitudinal study comparing anti-endothelial cell antibodies and anti-neutrophil cytoplasm antibodies,” American Journal of Kidney Diseases, vol. 22, no. 3, pp. 387–392, 1993. View at Google Scholar · View at Scopus
  116. D. P. D'Cruz, F. A. Housiau, G. Ramirez et al., “Antibodies to endothelial cells in systemic lupus erythematosus: a potential marker for nephritis and vasculitis,” Clinical and Experimental Immunology, vol. 85, no. 2, pp. 254–261, 1991. View at Google Scholar · View at Scopus
  117. G. Frampton, P. Hobby, A. Morgan, N. A. Staines, and J. S. Cameron, “A role for DNA in anti-DNA antibodies binding to endothelial cells,” Journal of Autoimmunity, vol. 4, no. 3, pp. 463–478, 1991. View at Publisher · View at Google Scholar · View at Scopus
  118. D. B. Cines, A. P. Lyss, M. Reeber, M. Bina, and R. J. DeHoratius, “Presence of complement-fixing anti-endothelial cell antibodies in systemic lupus erythematosus,” The Journal of Clinical Investigation, vol. 73, no. 3, pp. 611–625, 1984. View at Google Scholar · View at Scopus
  119. G. J. Perry, T. Elston, N. A. Khouri, T. M. Chan, J. S. Cameron, and G. Frampton, “Antiendothelial cell antibodies in lupus: correlations with renal injury and circulating markers of endothelial damage,” Quarterly Journal of Medicine, vol. 86, no. 11, pp. 727–734, 1993. View at Google Scholar · View at Scopus
  120. S. Matsuo, A. Fukatsu, M. L. Taub, P. R. Caldwell, J. R. Brentjens, and G. Andres, “Glomerulonephritis induced in the rabbit by antiendothelial antibodies,” The Journal of Clinical Investigation, vol. 79, no. 6, pp. 1798–1811, 1987. View at Google Scholar
  121. H. Fujii, K. Nakatani, N. Arita et al., “Intenalization of antibodies by endothelial cells via fibronectin implicating a novel mechanism in lupus nephritis,” Kidney International, vol. 64, no. 5, pp. 1662–1670, 2003. View at Publisher · View at Google Scholar · View at Scopus
  122. T. M. Chan and I. K. P. Cheng, “Identification of endothelial cell membrane proteins that bind anti-DNA antibodies from patients with systemic lupus erythematosus by direct or indirect mechanisms,” Journal of Autoimmunity, vol. 10, no. 5, pp. 433–439, 1997. View at Publisher · View at Google Scholar · View at Scopus
  123. T. M. Chan, P. M. Yu, K. L. C. Tsang, and I. K. P. Cheng, “Endothelial cell binding by human polyclonal anti-DNA antibodies: relationship to disease activity and endothelial functional alterations,” Clinical and Experimental Immunology, vol. 100, no. 3, pp. 506–513, 1995. View at Google Scholar · View at Scopus
  124. K. N. Lai, J. C. Leung, K. B. Lai, F. M. Lai, and K. C. Wong, “Increased release of von Willebrand factor antigen from endothelial cells by anti-DNA autoantibodies,” Annals of the Rheumatic Diseases, vol. 55, no. 1, pp. 57–62, 1996. View at Google Scholar · View at Scopus
  125. C. E. Carvalho-Pinto, M. I. García, M. Mellado et al., “Autocrine production of IFN-γ by macrophages controls their recruitment to kidney and the development of glomerulonephritis in MRL/lpr mice,” The Journal of Immunology, vol. 169, no. 2, pp. 1058–1067, 2002. View at Google Scholar · View at Scopus
  126. Z. Liu, R. Bethunaickan, W. Huang, M. Ramanujam, M. P. Madaio, and A. Davidson, “IFN-α confers resistance of systemic lupus erythematosus nephritis to therapy in NZB/W F1 mice,” The Journal of Immunology, vol. 187, no. 3, pp. 1506–1513, 2011. View at Google Scholar
  127. H. Hägele, R. Allam, R. D. Pawar, C. A. Reichel, F. Krombach, and H. J. Anders, “Double-stranded DNA activates glomerular endothelial cells and enhances albumin permeability via a toll-like receptor-independent cytosolic DNA recognition pathway,” The American Journal of Pathology, vol. 175, no. 5, pp. 1896–1904, 2009. View at Publisher · View at Google Scholar · View at Scopus
  128. A. M. Fairhurst, C. Xie, Y. Fu et al., “Type I interferons produced by resident renal cells may promote end-organ disease in autoantibody-mediated glomerulonephritis,” The Journal of Immunology, vol. 183, no. 10, pp. 6831–6838, 2009. View at Publisher · View at Google Scholar · View at Scopus
  129. K. A. Nath, “The tubulointerstitium in progressive renal disease,” Kidney International, vol. 54, no. 3, pp. 992–994, 1998. View at Publisher · View at Google Scholar · View at Scopus
  130. K. A. Nath, “Tubulointerstitial changes as a major determinant in the progression of renal damage,” American Journal of Kidney Diseases, vol. 20, no. 1, pp. 1–17, 1992. View at Google Scholar · View at Scopus
  131. W. C. Burns, P. Kantharidis, and M. C. Thomas, “The role of tubular epithelial-mesenchymal transition in progressive kidney disease,” Cells Tissues Organs, vol. 185, no. 1–3, pp. 222–231, 2007. View at Publisher · View at Google Scholar · View at Scopus
  132. J. W. G. V. Copeland, B. W. Beaumont, M. J. Merrilees, and H. L. Pilmore, “Epithelial-to-mesenchymal transition of human proximal tubular epithelial cells: effects of rapamycin, mycophenolate, cyclosporin, azathioprine, and methylprednisolone,” Transplantation, vol. 83, no. 6, pp. 809–814, 2007. View at Publisher · View at Google Scholar · View at Scopus
  133. Y. Liu, “Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention,” Journal of the American Society of Nephrology, vol. 15, no. 1, pp. 1–12, 2004. View at Publisher · View at Google Scholar · View at Scopus
  134. T. A. Wynn, “Cellular and molecular mechanisms of fibrosis,” The Journal of Pathology, vol. 214, no. 2, pp. 199–210, 2008. View at Publisher · View at Google Scholar · View at Scopus
  135. J. Yang and Y. Liu, “Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis,” The American Journal of Pathology, vol. 159, no. 4, pp. 1465–1475, 2001. View at Google Scholar · View at Scopus
  136. A. A. Eddy, “Molecular insights into renal interstitial fibrosis,” Journal of the American Society of Nephrology, vol. 7, no. 12, pp. 2495–2508, 1996. View at Google Scholar · View at Scopus
  137. A. A. Eddy, “Molecular basis of renal fibrosis,” Pediatric Nephrology, vol. 15, no. 3-4, pp. 290–301, 2000. View at Publisher · View at Google Scholar · View at Scopus
  138. Y. Liu, “New insights into epithelial-mesenchymal transition in kidney fibrosis,” Journal of the American Society of Nephrology, vol. 21, no. 2, pp. 212–222, 2010. View at Publisher · View at Google Scholar · View at Scopus
  139. D. W. Powell, C. C. Bertram, T. D. Cummins et al., “Renal tubulointerstitial fibrosis in OVE26 type 1 diabetic mice,” Nephron. Experimental Nephrology, vol. 111, no. 1, pp. e11–e19, 2009. View at Publisher · View at Google Scholar · View at Scopus
  140. T. Yamamoto, N. A. Noble, D. E. Miller, and W. A. Border, “Sustained expression of TGF-β1 underlies development of progressive kidney fibrosis,” Kidney International, vol. 45, no. 3, pp. 916–927, 1994. View at Google Scholar · View at Scopus
  141. M. J. Ryan, G. Johnson, J. Kirk, S. M. Fuerstenberg, R. A. Zager, and B. Torok-Storb, “HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney,” Kidney International, vol. 45, no. 1, pp. 48–57, 1994. View at Google Scholar · View at Scopus
  142. N. Ronda, P. Cravedi, L. Benozzi et al., “Early proinflammatory activation of renal tubular cells by normal and pathologic IgG,” Nephron. Experimental Nephrology, vol. 100, no. 2, pp. e77–e84, 2005. View at Publisher · View at Google Scholar · View at Scopus
  143. E. Koren, M. Koscec, M. Wolfson-Reichlin et al., “Murine and human antibodies to native DNA that cross-react with the A and D SnRNP polypeptides cause direct injury of cultured kidney cells,” The Journal of Immunology, vol. 154, no. 9, pp. 4857–4864, 1995. View at Google Scholar · View at Scopus
  144. A. Greka and P. Mundel, “Cell biology and pathology of podocytes,” Annual Review of Physiology, vol. 74, pp. 299–323, 2011. View at Google Scholar
  145. Z. Zhao, E. Weinstein, M. Tuzova et al., “Cross-reactivity of human lupus anti-DNA antibodies with α-actinin and nephritogenic potential,” Arthritis and Rheumatism, vol. 52, no. 2, pp. 522–530, 2005. View at Publisher · View at Google Scholar · View at Scopus
  146. H. A. Austin III, G. G. Illei, and J. E. Balow, “Lupus membranous nephropathy,” in Lupus Nephritis, E. J. Lewis, M. M. Schwartz, S. M. Korbet, and D. T. M. Chan, Eds., pp. 169–197, Oxford University Press, New York, NY, USA, 2011. View at Google Scholar
  147. A. Iwasaki and R. Medzhitov, “Toll-like receptor control of the adaptive immune responses,” Nature Immunology, vol. 5, no. 10, pp. 987–995, 2004. View at Publisher · View at Google Scholar · View at Scopus
  148. M. G. Robson, “Toll-like receptors and renal disease,” Nephron. Experimental Nephrology, vol. 113, no. 1, pp. e1–e7, 2009. View at Publisher · View at Google Scholar · View at Scopus
  149. J. Tian, A. M. Avalos, S. Y. Mao et al., “Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE,” Nature Immunology, vol. 8, no. 5, pp. 487–496, 2007. View at Publisher · View at Google Scholar · View at Scopus
  150. A. Lartigue, P. Courville, I. Auquit et al., “Role of TLR9 in anti-nucleosome and anti-DNA antibody production in lpr mutation-induced marine lupus,” The Journal of Immunology, vol. 177, no. 2, pp. 1349–1354, 2006. View at Google Scholar · View at Scopus
  151. B. Liu, Y. Yang, J. Dai et al., “TLR4 up-regulation at protein or gene level is pathogenic for lupus-like autoimmune disease,” The Journal of Immunology, vol. 177, no. 10, pp. 6880–6888, 2006. View at Google Scholar · View at Scopus
  152. M. Li, D. F. Carpio, Y. Zheng et al., “An essential role of the NF-κB/toll-like receptor pathway in induction of inflammatory and tissue-repair gene expression by necrotic cells,” The Journal of Immunology, vol. 166, no. 12, pp. 7128–7135, 2001. View at Google Scholar · View at Scopus
  153. T. K. Means, E. Latz, F. Hayashi, M. R. Murali, D. T. Golenbock, and A. D. Luster, “Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9,” The Journal of Clinical Investigation, vol. 115, no. 2, pp. 407–417, 2005. View at Publisher · View at Google Scholar · View at Scopus
  154. S. R. Christensen, J. Shupe, K. Nickerson, M. Kashgarian, R. Flavell, and M. J. Shlomchik, “Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus,” Immunity, vol. 25, no. 3, pp. 417–428, 2006. View at Publisher · View at Google Scholar · View at Scopus
  155. P. S. Patole, R. D. Pawar, M. Lech et al., “Expression and regulation of Toll-like receptors in lupus-like immune complex glomerulonephritis of MRL-Fas(lpr) mice,” Nephrology Dialysis Transplantation, vol. 21, no. 11, pp. 3062–3073, 2006. View at Publisher · View at Google Scholar · View at Scopus
  156. A. Benigni, C. Caroli, L. Longaretti et al., “Involvement of renal tubular toll-like receptor 9 in the development of tubulointerstitial injury in systemic lupus,” Arthritis and Rheumatism, vol. 56, no. 5, pp. 1569–1578, 2007. View at Publisher · View at Google Scholar · View at Scopus
  157. E. D. Papadimitraki, M. Tzardi, G. Bertsias, E. Sotsiou, and D. T. Boumpas, “Glomerular expression of toll-like receptor-9 in lupus nephritis but not in normal kidneys: implications for the amplification of the inflammatory response,” Lupus, vol. 18, no. 9, pp. 831–835, 2009. View at Publisher · View at Google Scholar · View at Scopus
  158. R. D. Pawar, A. Ramanjaneyulu, O. P. Kulkarni, M. Lech, S. Segerer, and H. J. Anders, “Inhibition of Toll-like receptor-7 (TLR-7) or TLR-7 plus TLR-9 attenuates glomerulonephritis and lung injury in experimental lupus,” Journal of the American Society of Nephrology, vol. 18, no. 6, pp. 1721–1731, 2007. View at Publisher · View at Google Scholar · View at Scopus
  159. X. Wu and S. L. Peng, “Toll-like receptor 9 signaling protects against murine lupus,” Arthritis and Rheumatism, vol. 54, no. 1, pp. 336–342, 2006. View at Publisher · View at Google Scholar · View at Scopus